Sailong Pharmaceutical Group Inc. logo

Sailong Pharmaceutical Group Inc. (002898)

Market Closed
16 Jul, 06:57
XSHE XSHE
¥
0. 37
-0.01
-2.6316%
¥
2.39B Market Cap
- P/E Ratio
0.02% Div Yield
9.91M Volume
- Eps
¥ 0.38
Previous Close
Add Transaction
Day Range
0.37 0.39
Year Range
0.3 17.49
Want to track 002898 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002898 closed Thursday lower at ¥0.37, a decrease of -2.6316% from Wednesday's close, completing a monthly increase of 8.8235% or ¥0.03. Over the past 12 months, 002898 stock lost -97.2834%.
002898 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, missed the consensus estimates by -0.0059%. On average, the company has surpassed earnings expectations by 0.0016%, based on the last three reports.
Sailong Pharmaceutical Group Inc. has completed 1 stock splits, with the recent split occurring on Jul 16, 2020.
The company's stock is traded on one exchange.

002898 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Sailong Pharmaceutical Group Inc. (002898) FAQ

What is the stock price today?

The current price is ¥0.37.

On which exchange is it traded?

Sailong Pharmaceutical Group Inc. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002898.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.02%.

What is its market cap?

As of today, the market cap is 2.39B.

Has Sailong Pharmaceutical Group Inc. ever had a stock split?

Sailong Pharmaceutical Group Inc. had 1 splits and the recent split was on Jul 16, 2020.

Sailong Pharmaceutical Group Inc. Profile

Biotechnology Industry
Healthcare Sector
Mr. Nan Gui Cai CEO
XSHE Exchange
CNE1000032S5 ISIN
CN Country
514 Employees
28 Jun 2024 Last Dividend
16 Jul 2020 Last Split
- IPO Date

Overview

Sailong Pharmaceutical Group Co., Ltd. is at the forefront of the pharmaceutical industry in China, specializing in the research, development, production, marketing, and servicing of pharmaceutical intermediates, raw materials, and preparations. The company encompasses a broad range of products that cater to various therapeutic areas, including cardiovascular, cerebrovascular, neurological, and digestive system ailments, as well as proton pump inhibitors, anti-infectives, anti-bleeding drugs, and analgesics. Initially known as Zhuhai Sailong Pharmaceutical Co.,Ltd., it underwent a rebranding in September 2021 to Sailong Pharmaceutical Group Co., Ltd. Since its establishment in 2002, the company has established its headquarters in Zhuhai, China, signifying its strategic positioning within the Chinese pharmaceutical industry.

Products and Services

The Sailong Pharmaceutical Group Co., Ltd. portfolio encompasses a wide range of pharmaceutical products and services aimed at addressing a variety of health conditions and therapeutic needs:

  • Esomeprazole Sodium: A proton pump inhibitor used to manage gastroesophageal reflux disease (GERD) and other conditions involving excessive stomach acid.
  • Ornithine Aspartate: Employed in the treatment of high ammonia levels and liver diseases, supporting liver function and detoxification processes.
  • Thymus: Utilized for boosting the immune system and other health benefits.
  • Argatroban: A direct thrombin inhibitor used in preventing and treating thrombosis in patients with certain conditions.
  • Tigecycline: An antibiotic for the treatment of a variety of bacterial infections, especially those resistant to traditional antibiotics.
  • Monosialotetrahexose Ganglioside Sodium: Used in the treatment of neurological conditions to promote nerve regeneration and repair.
  • Cerebroprotein Hydrolysate: Aimed at the treatment of cerebrovascular diseases, enhancing brain function and recovery.
  • Milrinone: A medication that helps improve heart function and increases cardiac output, commonly used in the treatment of heart failure.
  • Parecoxib Sodium: A non-steroidal anti-inflammatory drug (NSAID) used for pain relief and to reduce inflammation.
  • Tranexamic Acid: An anti-bleeding drug that helps in reducing blood loss during surgeries and in conditions like heavy menstrual bleeding.
  • Clindamycin Phosphate: An antibiotic used for treating a wide array of bacterial infections, particularly those of the skin and soft tissues.
  • Pantoprazole Sodium: Another proton pump inhibitor that reduces stomach acid, aiding in the treatment of erosive esophagitis and other acid-related stomach and throat problems.

Contact Information

Address: Everbright International Trade Center, Zhuhai, China, 519015
Phone: 86 75 6388 2955